Staff Reports
A leading advocate for transgender care, Dr. Johanna Olson-Kennedy, is under fire for withholding a taxpayer-funded study that contradicts the effectiveness of puberty-blocking drugs for children. The study, which cost ten million dollars and spanned nine years, found that children did not experience improved mental health after receiving these treatments. This is crucial information for families and individuals in the transgender community making life-altering decisions.
Dr. Olson-Kennedy’s refusal to release the study because it could be used as evidence against puberty-blockers has raised concerns about transparency and the withholding of important information. The study’s findings challenge the narrative that puberty-blockers are a beneficial treatment for children with gender dysphoria, as the mental health outcomes did not show significant improvement even after two years of treatment.
The NIH paid millions to conduct a woke study on gender reassignment treatments, but the findings didn't support their radical agenda.
Now they're trying to withhold the report and bury themselves in the fake science of their ideology.
Not on my watch. https://t.co/1OANHCMYyT
— Representative Lisa McClain (@RepLisaMcClain) November 4, 2024
Critics argue that the study’s omission of data on prior psychiatric drug use in these children raises questions about the comprehensive understanding of the effects of transgender interventions. The potential connection between psychiatric drugs and the desire to transition is highlighted as an area of concern, especially considering the known risks and side-effects of these medications on mental health.
The lack of long-term studies on the safety and efficacy of puberty-blockers for transgender youth has raised alarms among medical professionals and organizations like the American College of Pediatricians, who have cautioned against experimental treatments for children with gender dysphoria. The decision to prescribe these drugs off-label, without FDA approval for use in transgender children, further adds to the uncertainties surrounding the potential risks and consequences of such interventions.
The controversy surrounding Dr. Olson-Kennedy’s handling of the study underscores the need for transparency and accountability in medical research, especially when taxpayer funds are involved. The concerns raised by critics highlight the complexities and ethical considerations surrounding transgender interventions, particularly in children with mental health issues.
